21415050

Source:http://linkedlifedata.com/resource/pubmed/id/21415050

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0008976, umls-concept:C0025677, umls-concept:C0332464, umls-concept:C0439831, umls-concept:C0564405, umls-concept:C0681906, umls-concept:C0723011, umls-concept:C0936012, umls-concept:C1872109, umls-concept:C1999230, umls-concept:C2828008
pubmed:issue	6
pubmed:dateCreated	2011-5-4
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00160602
pubmed:abstractText	To assess the impact of certolizumab pegol (CZP) on patient-reported outcomes (PROs) in rheumatoid arthritis (RA), and to interpret these results using number needed to treat (NNT), and associations between PRO responses and longer term outcomes.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-10728742, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-11690728, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-12595618, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-12634229, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-12831398, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-14584021, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-15529377, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-16206362, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-16385520, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-16652437, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-17304654, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-17469162, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-17965118, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-18055266, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-18085743, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-18092260, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-18415967, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-18419803, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-18975346, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19004044, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19015206, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19015207, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19116965, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19293160, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19364730, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19487267, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19635732, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19909548, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-19910301, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-20108988, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-20950126, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-7362664, http://linkedlifedata.com/resource/pubmed/commentcorrection/21415050-8478873
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/certolizumab pegol
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1468-2060
pubmed:author	pubmed-author:BurmesterGerd RGR, pubmed-author:CoteurGeoffroyG, pubmed-author:HiepeFalkF, pubmed-author:KhannaDineshD, pubmed-author:MeasePhilipP, pubmed-author:NikaïEnkeleidaE, pubmed-author:SchiffMichaelM, pubmed-author:SmolenJosef SJS, pubmed-author:StrandVibekeV, pubmed-author:van VollenhovenRonald FRF
pubmed:issnType	Electronic
pubmed:volume	70
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	996-1002
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21415050-Adult, pubmed-meshheading:21415050-Antibodies, Monoclonal, Humanized, pubmed-meshheading:21415050-Antirheumatic Agents, pubmed-meshheading:21415050-Arthritis, Rheumatoid, pubmed-meshheading:21415050-Dose-Response Relationship, Drug, pubmed-meshheading:21415050-Drug Administration Schedule, pubmed-meshheading:21415050-Drug Therapy, Combination, pubmed-meshheading:21415050-Epidemiologic Methods, pubmed-meshheading:21415050-Fatigue, pubmed-meshheading:21415050-Female, pubmed-meshheading:21415050-Humans, pubmed-meshheading:21415050-Immunoglobulin Fab Fragments, pubmed-meshheading:21415050-Male, pubmed-meshheading:21415050-Methotrexate, pubmed-meshheading:21415050-Middle Aged, pubmed-meshheading:21415050-Pain, pubmed-meshheading:21415050-Pain Measurement, pubmed-meshheading:21415050-Polyethylene Glycols, pubmed-meshheading:21415050-Quality of Life, pubmed-meshheading:21415050-Treatment Outcome
pubmed:year	2011

More...